Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Android iOS
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Search results for:

everolimus

everolimus
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Zortress TABLET, ORAL 0.25 mg      
Zortress TABLET, ORAL 0.5 mg, 0.75 mg    
Afinitor TABLET, ORAL 5 mg, 10 mg      
VIEW MORE Antineoplastic Agents
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

everolimus (Zortress)

  • 0.5 mg tablet
  • 0.75 mg tablet

everolimus (Zortress)

  • TWO 0.25 mg tablets (TOTAL: 0.5 mg)
  • THREE 0.25 mg tablets (TOTAL: 0.75 mg)

Oral Chemotherapy Drug Pharmacist Education

Oral Chemotherapy TOC Information

Zortress medication guide

Afinitor is classified as non-formulary, not stocked. Initiation should be deferred to after discharge and inpatients continuing maintenance therapy should use their home supply.

Reviewed: June 23, 2009 (Afinitor) and July 27, 2010 (Zortress)

Last updated: Mar. 5, 2025
Rhazdrugs everolimus






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved